May 25, 2021 / 02:00PM GMT
Sebastian Vogel - UBS Investment Bank, Research Division - Director & Sell Side Equity Research Analyst
Good morning, everybody, and many thanks for joining us today at the presentation of Tecan. My name is Sebastian Vogel of the UBS Swiss small and midcap research team.
As usual, we'll start off with a presentation by Tecan. And afterwards, depending on the time left, there will be, of course, hopefully, quite some time left also for the Q&A. (Operator Instructions)
And without further ado, I warmly welcome Mr. Achim von Leoprechting, CEO of Tecan. And with that, I'll hand over the word directly over to you.
Achim von Leoprechting - Tecan Group Ltd. - Head of the Partnering Business Division, CEO & Member of Management Board
Thank you very much, Sebastian, and thank you very much also for the invitation and the opportunity to speak to such a distinguished audience this morning. As Sebastian, you described, we will go through a self-service presentation. So I will reference the slides that I'm speaking to.
So maybe before
Tecan Group AG at UBS Global Healthcare Virtual Conference Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers